Letter to EditorInternational Journal of Pharmaceutical InvestigationVol. 2 | Issue 4 | pp. 218Open access
Delivery of nutraceuticals using nanotechnology
- 1,2*
- 1 Wiwanitkit House, Bangkhae, Bangkok, Thailand, Hainan Medical University, CHINA.
- 2 Joseph Ayobabalola University, Nigeria, Faculty of Medicine, University of Nis, SERBIA.
Published in International Journal of Pharmaceutical Investigation
Correspondence: Viroj Wiwanitkit
Wiwanitkit House, Bangkhae, Bangkok, Thailand, Hainan Medical University, CHINA.; Joseph Ayobabalola University, Nigeria, Faculty of Medicine, University of Nis, SERBIA.
Email: wviroj@yahoo.com
- DOI:
- 10.4103/2230-973X.107008
How to cite
Wiwanitkit, V. Delivery of nutraceuticals using nanotechnology. International Journal of Pharmaceutical Investigation, 2(4), 218. https://doi.org/10.4103/2230-973X.107008
Abstract
The editorial on delivery of nutraceuticals using nanotechnology is very interesting.[1] As noted, successful formulation of new nanosubstance is the hope. However, the effectiveness and safety is still the consideration.[1,2] The concern is further testing of the new nano ‑product. A good testing system is needed. Generally in vitro experiment might be convenient but it cannot answer the question. There are many concerns of the nano‑products. The in vivo stability of the new product must be studied. Indeed, the nanosubstance is usually highly sensitive and aggregation can easily occur.
Subject
Article metadata
| Title | Delivery of nutraceuticals using nanotechnology |
|---|---|
| Authors | Viroj Wiwanitkit |
| Affiliations | Wiwanitkit House, Bangkhae, Bangkok, Thailand, Hainan Medical University, CHINA.; Joseph Ayobabalola University, Nigeria, Faculty of Medicine, University of Nis, SERBIA. |
| Corresponding author | wviroj@yahoo.com |
| Journal | International Journal of Pharmaceutical Investigation |
| Volume / Issue | Vol. 2, Issue 4 |
Also in this issue
- Formulation strategies for drug delivery of tacrolimus: An overviewpp. 169–175
- Formulation and optimisation of raft‑forming chewable tablets containing H2 antagonistpp. 176–182
- Formulation and evaluation of carvedilol melt‑in‑mouth tablet using mucoadhesive polymer and PEG‑6‑stearate as hydrophilic waxy binderpp. 183–188
- Influence of excipients and processing conditions on the development of agglomerates of racecadotril by crystallo‑co‑agglomerationpp. 189–200
- Formulation and evaluation of Ketoconazole niosomal gel drug delivery systempp. 201–207